Fulfilling the Promise of Much-Needed Cures

Research2Reality video thumbnail

Regenerative medicine could revolutionize healthcare by providing actual cures to so many diseases where we are currently only treating symptoms. But the field is so new that there are exceptional hurdles to getting great ideas from the bench to the clinic.

Michael May is the president and CEO of CCRM, and he is bringing together the players who are needed to translate stem cell discoveries into commercial products.

This video was created by Research2Reality (R2R), which is a groundbreaking initiative that shines a spotlight on world-class scientists engaged in innovative and leading edge research in Canada. R2R’s video series celebrates the success of researchers who are establishing the new frontiers of science and to share the impact of their discoveries with the public.

Canada eyes leading role in regenerative medicine

Scientists tour CCRM's laboratory facility

Getting a promising new product to market can be a challenge, and this is especially true in medicine. From the earliest stages of development through to clinical trials, proving that new therapeutics work can take a lot of time and investment. CCRM bridges the gap between the lab and the clinic, helping accelerate stem cell therapies to the market.

This video was created by Research2Reality (R2R), which is a groundbreaking initiative that shines a spotlight on world-class scientists engaged in innovative and leading edge research in Canada. R2R’s video series celebrates the success of researchers who are establishing the new frontiers of science and to share the impact of their discoveries with the public.

All other pages contact

For more information, please contact us.
Font Resize
Enable Contrast